Inflammatory mediators in dengue virus infection in children: Interleukin-8 and its relationship to neutrophil degranulation

Infection and Immunity

Volumn 68, Issue 2, 2000, Pages 702-707

  Juffrie, M ^a   Van Der Meer, G M ^b   Hack, C E ^b   Haasnoot, K ^b   Sutaryo, ^a   Veerman, A J P ^b   Thijs, L G ^b  

^a GADJAH MADA UNIVERSITY   (Indonesia)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 8; LACTOFERRIN; LEUKOCYTE ELASTASE;

ARTICLE; CONTROLLED STUDY; DEGRANULATION; DENGUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; NEUTROPHIL; PRIORITY JOURNAL;

CELL DEGRANULATION; CHILD; DENGUE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; LACTOFERRIN; LEUKOCYTE ELASTASE; NEUTROPHILS; SHOCK, SEPTIC;

EID: 0033959141     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.2.702-707.2000     Document Type: Article

References (54)

1. Baggiolini, M., A. Walz, and S. L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J. Clin. Investig. 84:1045-1049.
2. Bainton, D. F. 1973. Sequential degranulation of the two types of polymorphonuclear leukocyte granules during phagocytosis of microorganisms. J. Cell Biol. 58:249-254.
3. Bethell, D. B., K. Flobbe, C. X. Thanh Phuong, et al. 1998. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J. Infect. Dis. 177:778-782.
4. Bhakdi, S., and M. D. Kazatchkine. 1990. Pathogenesis of dengue: an alternative hypothesis. Southeast Asian J. Trop. Med. Public Health 21:652-656.
5. Bhamarapravati, N., P. Tuchinda, and V. Boonyapaknavik. 1967. Pathology of Thailand hemorrhagic fever: a study of 100 autopsy cases. Ann. Trop. Med. Parasitol. 61:500-510.
6. Boonpucknavig, V., N. Bhamarapravati, S. Boonpucknavig, P. Futrakul, and P. Tanpaichitr. 1976. Glomerular changes in dengue hemorrhagic fever. Arch. Pathol. Lab. Med. 100:206-212.
7. Boonpucknavig, S., V. Boonpucknavig, N. Bhamarapravati, and S. Nimmanitya. 1979. Immunofluorescence study of skin rash in patients with dengue hemorrhagic fever. Arch. Pathol. Lab. Med. 103:463-466.
8. Carveth, H. J., J. F. Bohnsack, T. M. McIntyre, M. Baggiolini, S. M. Prescott, and G. A. Zimmerman. 1989. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. Biochem. Biophys. Res. Commun. 162:387-393.
9. Colditz, I., R. Zwahlen, B. Dewald, and M. Baggiolini. 1989. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. Am. J. Pathol. 134:755-760.
10. Collins, P. D., P. J. Jose, and T. J. Williams. 1991. The sequential generation of neutrophil chemoattractant proteins in acute inflammation in the rabbit in vivo: relationship between C5a and proteins with the characteristics of IL-8/neutrophil-activating protein 1. J. Immunol. 146:677-684.
11. Downey, G. P. 1994. Mechanism of leukocyte motility and chemotaxis. Curr. Opin. Immunol. 6:113-124.
12. Estensen, R. D., J. G. White, and B. Holmes. 1974. Specific degranulation of human polymorphonuclear leukocytes. Nature 248:347-349.
13. Goetzl, E. J., and I. M. Goldstein. 1985. Cellular components of inflammation: granulocytes, p. 115-144. In W. N. Kelly, E. D. Harris, S. Ruddy, and C. B. Sledge (ed.), Textbook of rheumatology. The W. B. Saunders Co., Philadelphia, Pa.
14. Goldstein, I. M., S. T. Hoffstein, and G. Weissmann. 1975. Mechanism of lysosomal enzyme release from human polymorphonuclear leukocytes. Effects of phorbol myristate. J. Cell Biol. 66:647-651.
15. Gubler, D. J., D. Reed, L. Rosen, and J. C. Hitchcock. 1978. Epidemiologic, clinical, and virologie observations on dengue in the Kingdom of Tonga. Am. J. Trop. Med. Hyg. 27:581-589.
16. Hack, C. E., M. Hart, R. J. M. Strack van Schijndel, et al. 1992. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect. Immun. 60:2835-2842.
17. Hulstead, S. B. 1980. Immunological parameters of togavirus disease syndromes, p. 107-173. In R. W. Schlesinger (ed.), The togaviruses. Academic Press, Inc., New York, N.Y.
18. Halstead, S. B. 1990. Global epidemiology of dengue hemorrhagic fever. Southeast Asian J. Trop. Med. Public Health 21:636-641.
19. Halstead, S. B. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev. Infect. Dis. 11:830-839.
20. Halstead, S. B. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J. Biol. Med. 42:350-362.
21. Harada, A., N. Sekido, T. Akahoshi, T. Wada, N. Mukaida, and K. Matsushima. 1994. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukoc. Biol. 56:559-564.
22. Hechtman, D. H., M. I. Cybulsky, H. J. Fuchs, J. B. Baker, and M. A. Gimbrone, Jr. 1991. Intravascular IL-8: inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J. Immunol. 147:883-892.
23. Hober, D., L. Poli, B. Roblin, et al. 1993. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) in dengue-infected patients. Am. J. Trop. Med. Hyg. 48:324-331.
24. Huber, A. R., S. L. Kunkel, R. F. Todd III, and S. J. Weiss. 1991. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254:99-102.
25. Johnson, U., K. Ohlsson, and I. Olsson. 1976. Effects of granulocyte neutral proteases on complement components. Scand. J. Immunol. 5:421-426.
26. Johnston, R. B., Jr, J. E. Lehmeyer, and L. A. Guthrie. 1976. Generation of Superoxide anion and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G. J. Exp. Med. 143:1551-1556.
27. Keuter, M., E. Dharmana, M. H. Gasem, et al. 1994. Pattern of proinflammatury cytokines and inhibitors during typhoid fever. J. Infect. Dis. 169: 1306-1311.
28. Kliks, S. C., A. Nisalak, W. E. Brandt, L. Wahl, and D. C. Burke. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40:444-451.
29. Kurane, I., B. L. Innis, S. Nimmannitya, A. Nisalak, A. Meager, and F. A. Ennis. 1993. High levels of interferon alpha in the sera of children with dengue virus infection. Am. J. Trop. Med. Hyg. 48:222-229.
30. Kurane, I., J. Janus, and F. A. Ennis. 1992. Dengue virus infection of human skin fibroblasts in vitro production of TFN-β, IL-6 and GM-CSF. Arch. Virol. 124:21-30.
31. Merck, E. 1983. Hematological laboratory methods. GIT Verlag-Earnst Gieblre, Darmstadt, Germany.
32. Monath, T. P. 1985. Flaviviruses, p. 955-1004. In B. W. Fields, D. M. Knipe, R. M. Chanock, J. L. Malnick, B. Roizman, and R. E. Shope (ed.), Virology. Raven Press, New York, N.Y.
33. Morens, D. M., G. E. Sather, D. J. Gubler, M. Rammohan, and J. P. Woodall. 1987. Dengue shock syndrome in an American traveler with primary dengue 3 infection. Am. J. Trop. Med. Hyg. 36:424-426.
34. Nuijens, J. H., J. J. Abbink, Y. T. Wachtfogel, R. W. Coleman, A. J. Eerenberg, D. Dors, A. J. Kamp, R. J. Strack van Schindel, L. G. Thijs, and C. E. Hack. 1992. Plasma elastase α1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J. Lab. Clin. Med. 119:159-168.
35. Patterson, C. E., J. W. Barnard, J. E. Lafuze, M. T. Hull, S. J. Baldwin, and R. A. Rhoades. 1988. The role of activation of neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med. 167:1547-1559.
36. Peveri, P., A. Walz, B. Dewald, and M. Baggiolini. 1994. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med. 167:1547-1559.
37. Raghupathy, R., U. C. Chaturvedi, H. Al-Sayer, et al. 1998. Elevated levels of IL-8 in dengue hemorrhagic fever. J. Med. Virol. 56:280-285.
38. Sabin, A. B. 1952. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1:30-50.
39. Sangkawibha, N., S. Rojanasuphot, S. Ahandrik, S. Viriyaspongse, S. Jatanasen, V. Salitul, B. Phanthumachinda, and S. B. Halsted. 1984. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120:653-669.
40. Schlesinger, R. W. 1977. Dengue viruses. Springer-Verlag, New York, N.Y.
41. Schmidt, W., R. Egbring, and K. Havemann. 1975. Effect of elastase-like and chymotrypsin-like neutral proteases from human granulocytes on isolated clotting factors. Thromb. Res. 6:326-329.
42. Schroder, J. M., U. Mrowietz, E. Morita, and E. Christophers. 1987. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin-1 activity. J. Immunol. 139:3473-3483.
43. Scott, R. M., S. Nimmannitya, W. H. Bancroft, and P. Mansuwan. 1976. Shock syndrome in primary dengue infections. Am. J. Trop. Med. Hyg. 25: 866-874.
44. Smedly, L. A., M. G. Tonnesen, R. A. Sandhaus, C. Haslett, L. A. Guthrie, R. B. Johnston, Jr., P. M. Henson, and G. S. Worthen. 1986. Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essensial role of neutrophil elastase. J. Clin. Investig. 77:1233-1243.
45. 2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J. Exp. Med. 167:1364-1376.
46. Van Damme, J. 1991. Interleukin-8 and related molecules, p. 201-214. In A. W. Thomson (ed.), The cytokine handbook. Academic Press, London, England.
47. Varani, J., I. Ginsburg, L. Schuger, D. F. Gibbs, J. Bromberg, K. J. Johnson, J. S. Ryan, and P. A. Ward. 1989. Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. Am. J. Pathol. 135: 435-438.
48. Velzing, J., J. Groen, M. T. Drouet, G. van Amerongen, C. Copra, A. D. Osterhaus, and V. Deubel. 1999. Induction of protective immunity against dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines. Vaccine 17:1312-1320.
49. Vitarana, T., H. de Silva, N. Withana, and C. Gunasekera. 1991. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. Ceylon Med. J. 36:63-65.
50. Weiss, S. J., J. Young, A. LoBuglio, A. Slivka, and N. Nimeh. 1981. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J. Clin. Investig. 68:714-718.
51. Westwick, J., S. W. Li, and R. D. Camp. 1989. Novel neutrophil-stimulating peptides. Immunol. Today 10:146-147.
52. World Health Organization. 1997. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. World Health Organization, Geneva. Switzerland.
53. Yadav, M., K. R. Kamath, N. Iyngkaran, and M. Sinniah. 1991. Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders? Microbiol. Immunol. 89:45-50.
54. Yoshimura, T., K. Matsushima, S. Tanaka, et al. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 84:9233-9237.